Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 7/20 | 0.78 |
| ▸ | FLT1 | P17948 | 4/20 | 0.78 |
| ▸ | FLT4 | P35916 | 4/20 | 0.78 |
| ▸ | PRKACA | P17612 | 1/20 | 0.49 |
| ▸ | PRKACG | P22612 | 1/20 | 0.49 |
| ▸ | PRKACB | P22694 | 1/20 | 0.49 |
| ▸ | ASH1L | Q9NR48 | 5/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.41 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.36 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7976518 | 0.92 | KDR (0.72) | KDRFLT1FLT4PRKACAPRKACG | |
| SCHEMBL7976092 | 0.90 | KDR (0.70) | KDRFLT1FLT4PRKACAPRKACG | |
| SCHEMBL7994231 | 0.90 | KDR (0.70) | KDRFLT1FLT4PRKACAPRKACG | |
| SCHEMBL7990966 | 0.89 | KDR (0.63) | KDRFLT1FLT4PRKACAPRKACG | |
| SCHEMBL7987886 | 0.89 | KDR (0.63) | KDRFLT1FLT4PRKACAPRKACG | |
| SCHEMBL7547790 | 0.88 | KDR (0.68) | KDRFLT1FLT4PRKACAPRKACG | |
| SCHEMBL7547755 | 0.88 | KDR (1.00) | KDRFLT1FLT4PRKACAPRKACG | |
| SCHEMBL7977281 | 0.87 | KDR (0.61) | KDRFLT1FLT4PRKACAPRKACG | |
| SCHEMBL7986720 | 0.85 | KDR (0.59) | KDRFLT1FLT4PRKACAPRKACG | |
| SCHEMBL7986816 | 0.84 | KDR (0.58) | KDRFLT1FLT4PRKACAPRKACG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1147107-A4 | NOVEL ANGIOGENESIS INHIBITORS | MERCK & CO INC (US) | 2002-05-22 | — | — | EP | claimed |
| EP-1147107-A1 | NOVEL ANGIOGENESIS INHIBITORS | Merck & Co., Inc. (US) | 2001-10-24 | — | — | EP | claimed |
| WO-2000043393-A1 | NOVEL ANGIOGENESIS INHIBITORS | MERCK & CO., INC. (US) | 2000-07-27 | — | — | WO | claimed |
| EP-1147107-A4 | NOVEL ANGIOGENESIS INHIBITORS | MERCK & CO INC (US) | 2002-05-22 | — | — | EP | disclosed |
| EP-1147107-A1 | NOVEL ANGIOGENESIS INHIBITORS | Merck & Co., Inc. (US) | 2001-10-24 | — | — | EP | disclosed |
| US-6265403-B1 | TYROSINE INHIBITORS | MERCK & CO., INC. | 2001-07-24 | — | — | US | disclosed |
| WO-2000043393-A1 | NOVEL ANGIOGENESIS INHIBITORS | MERCK & CO., INC. (US) | 2000-07-27 | — | — | WO | disclosed |